HYBE is trading 4.03% down at KRW 180,900 amid uncertainty about BTS’s activities after its first-half 2027 tour schedule. - Eugene Investment & Securities said visibility on BTS’s plans is needed for a near-term share-price rebound; it maintained Buy but cut its target price 14.7% to KRW 290,000. - The firm expects strong third-quarter results, and recent coverage cited BTS tour revenue expectations; available reports do not establish the analyst view directly caused the decline.